BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36858922)

  • 1. Local treatment Associated With Prognosis among Men With Metastatic Prostate Cancer: A SEER-Based Study.
    Zhou J; Cao Y; Chen H; Wu Y; Ding J; Qi J
    Clin Genitourin Cancer; 2023 Jun; 21(3):e204-e215. PubMed ID: 36858922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
    Culp SH; Schellhammer PF; Williams MB
    Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer.
    Miao Q; Wei Z; Liu C; Ye Y; Cheng G; Song Z; Chen K; Zhang Y; Chen J; Yue C; Ruan H; Zhang X
    Front Oncol; 2023; 13():1130680. PubMed ID: 37207146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations.
    Ślusarczyk A; Baboudjian M; Zapała P; Yanagisawa T; Miszczyk M; Chlosta M; Krumpoeck P; Moschini M; Gandaglia G; Ploussard G; Rivas JG; Życzkowski M; Karakiewicz PI; Radziszewski P; Leapman MS; Shariat SF; Rajwa P
    Prostate; 2023 Nov; 83(15):1504-1515. PubMed ID: 37545342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes.
    Preisser F; Chun FKH; Pompe RS; Heinze A; Salomon G; Graefen M; Huland H; Tilki D
    Eur Urol; 2019 Jul; 76(1):106-114. PubMed ID: 30772034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Therapy Improves Survival in Metastatic Prostate Cancer.
    Leyh-Bannurah SR; Gazdovich S; Budäus L; Zaffuto E; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Steuber T; Huland H; Graefen M; Karakiewicz PI
    Eur Urol; 2017 Jul; 72(1):118-124. PubMed ID: 28385454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis.
    Liu S; Wang XY; Huang TB; Niu Q; Yao K; Song X; Zhou SY; Chen Z; Zhou GC
    Ann Palliat Med; 2020 Jul; 9(4):1708-1717. PubMed ID: 32527134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
    Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the Survival Outcomes of Radical Prostatectomy
    Guo X; Xia H; Su X; Hou H; Zhong Q; Wang J
    Front Oncol; 2021; 11():797462. PubMed ID: 34900748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer.
    Rusthoven CG; Jones BL; Flaig TW; Crawford ED; Koshy M; Sher DJ; Mahmood U; Chen RC; Chapin BF; Kavanagh BD; Pugh TJ
    J Clin Oncol; 2016 Aug; 34(24):2835-42. PubMed ID: 27325855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.
    Fossati N; Karnes RJ; Boorjian SA; Moschini M; Morlacco A; Bossi A; Seisen T; Cozzarini C; Fiorino C; Noris Chiorda B; Gandaglia G; Dell'Oglio P; Joniau S; Tosco L; Shariat S; Goldner G; Hinkelbein W; Bartkowiak D; Haustermans K; Tombal B; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2017 Jun; 71(6):886-893. PubMed ID: 27484843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing effectiveness of radical prostatectomy versus external beam radiotherapy in patients with locally advanced prostate cancer: A population-based analysis.
    Zhou X; Jin K; Qiu S; Jin D; Liao X; Tu X; Zheng X; Li J; Yang L; Wei Q
    Medicine (Baltimore); 2020 Aug; 99(34):e21642. PubMed ID: 32846773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients.
    Wenzel M; Collà Ruvolo C; Würnschimmel C; Nocera L; Tian Z; Saad F; Briganti A; Tilki D; Graefen M; Becker A; Roos F; Mandel P; Chun FKH; Karakiewicz PI
    Prostate; 2022 Jan; 82(1):78-85. PubMed ID: 34633102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer.
    Jang WS; Cho KS; Kim KH; Yoon CY; Kang YJ; Lee JY; Ham WS; Rha KH; Hong SJ; Choi YD
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):298-304. PubMed ID: 27349499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
    Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.
    Heidenreich A; Fossati N; Pfister D; Suardi N; Montorsi F; Shariat S; Grubmüller B; Gandaglia G; Briganti A; Karnes RJ
    Eur Urol Oncol; 2018 May; 1(1):46-53. PubMed ID: 31100228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The U Shape of Prostate-specific Antigen and Prostate Cancer-specific Mortality in High-grade Metastatic Prostate Adenocarcinoma.
    Wang J; Abudurexiti M; Shao N; Wei Y; Zhu Y; Ye DW
    Eur Urol Focus; 2020 Jan; 6(1):53-62. PubMed ID: 30217630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.